This inventor holds 1 USPTO granted patent. Top assignee: Science Union Et Cie. Active years: 1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1982
Title: The Innovative Contributions of Francoise Arnaud
Introduction
Francoise Arnaud is a notable inventor based in La Garenne Colombes, France. She has made significant contributions to the field of medicine, particularly in the treatment of hematological insufficiencies. Her innovative approach has led to the development of a unique method that addresses critical health issues.
Latest Patents
Francoise Arnaud holds a patent for a method of treating insufficiencies in hematosis with almitrine. This method involves treating patients suffering from conditions such as hypoxemia, cardiac insufficiency, and polyglobulia. The treatment utilizes the compound almitrine or its pharmaceutically-acceptable salts in extremely low daily dosages, ranging from 0.5 to 3 mg/kg orally or 0.05 to 0.3 mg/kg intravenously. The oral unit dosage form contains between 20 and 70 mg of the active ingredient, with a preferred dosage of about 50 mg.
Career Highlights
Arnaud's career is marked by her dedication to advancing medical treatments. She has worked diligently to develop her patented method, which showcases her commitment to improving patient outcomes. Her work has the potential to significantly impact the treatment of various hematological conditions.
Collaborations
Francoise Arnaud has collaborated with esteemed colleagues, including Etienne Labeyrie and Jean-Pierre Poirier. These partnerships have fostered a collaborative environment that enhances the development of innovative medical solutions.
Conclusion
Francoise Arnaud's contributions to the field of medicine through her innovative patent demonstrate her expertise and commitment to improving healthcare. Her work continues to inspire advancements in the treatment of hematological insufficiencies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile